2214-03-1 Usage
Uses
Used in Pharmaceutical Research and Development:
1,4,5,6-tetrahydrocyclopenta[c]pyrazole(SALTDATA: 0.8HCl) is used as a building block for the synthesis of various biologically active compounds. Its unique structure and properties make it a valuable component in the development of new drugs and pharmaceuticals.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1,4,5,6-tetrahydrocyclopenta[c]pyrazole(SALTDATA: 0.8HCl) is utilized for its potential applications in the discovery and design of new drugs. Its heterocyclic nature and ability to form stable complexes with other molecules contribute to its significance in this industry.
Used in Drug Discovery:
1,4,5,6-tetrahydrocyclopenta[c]pyrazole(SALTDATA: 0.8HCl) plays a crucial role in drug discovery, where it is employed to identify and develop new therapeutic agents. Its versatile chemical properties and potential to interact with various biological targets make it an essential tool in the search for novel pharmaceuticals.
Overall, 1,4,5,6-tetrahydrocyclopenta[c]pyrazole(SALTDATA: 0.8HCl) is a valuable chemical compound with a wide range of applications in various industries, particularly in the fields of pharmaceutical research, medicinal chemistry, and drug discovery. Its unique structure and properties make it a promising candidate for the development of new and innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 2214-03-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,1 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2214-03:
(6*2)+(5*2)+(4*1)+(3*4)+(2*0)+(1*3)=41
41 % 10 = 1
So 2214-03-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2/c1-2-5-4-7-8-6(5)3-1/h4H,1-3H2,(H,7,8)
2214-03-1Relevant articles and documents
Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
-
, (2008/06/13)
Compounds of the formula STR1 wherein R21 and R22 are as defined in the specification which are intermediates useful in the preparation of compounds of the formula STR2 and the pharmaceutically acceptable salts thereof, wherein Q and R1 are as defined in the specification. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.
New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase
-
, (2008/06/13)
Compounds of the formula the pharmaceutically acceptable salts thereof, wherein Q and R1 are as defined below, and novel carboxylic acid and acid halide intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.
Cephem compounds having 3-bicyclic heterocyclic cation groups
-
, (2008/06/13)
The invention relates to cephem compounds of high antimicrobial activity of the formula: STR1 wherein R1 is amino or protected amino, R2 is lower aliphatic hydrocarbon group, R3 is a group of the formula: STR2 wherein m is 0 and or 1, and n is 1 or 2, which may have a lower alkyl substituent at the N atom, and X is CH or N, and pharmaceutically acceptable salts thereof.
